Table 1.
Body weights, TAF, SAF, and VAF measured by computed tomography and factored for body weight or femur length in HAF rats and placebo controls, aged 12 wk
| BW, g | TAF, mm3/g | SAF, mm3/g | VAF, mm3/g | |
|---|---|---|---|---|
|
Fat mass factored for body weight | ||||
| Placebo | 230.6 ± 4.0 | 4.33 ± 0.38 | 1.52 ± 0.11 | 2.69 ± 0.31† |
| HAF | 329.0 ± 11.3* | 4.47 ± 0.27 | 2.16 ± 0.16* | 2.21 ± 0.11 |
| Femur length, cm | TAF, mm3/cm | SAF, mm3/cm | VAF, mm3/cm | |
|---|---|---|---|---|
|
Fat mass factored for femur length | ||||
| Placebo | 3.47 ± 0.11 | 288.5 ± 26.8 | 101.1 ± 7.86 | 179.1 ± 21.0† |
| HAF | 3.58 ± 0.09 | 409.4 ± 23.5* | 197.3 ± 9.78* | 203.4 ± 17.1 |
Values are means ± SE; n = 4 rats/group. HAF, hyperandrogenemic female; BW, body weight; TAF, total abdominal fat; SAF, subcutaneous abdominal fat; VAF, visceral abdominal fat.
*
P < 0.05, HAF vs. placebo.
†
P < 0.05, VAF vs. SAF in the same group.